Full Length Research Paper
References
|
Agarwal K, Alonso P, Chico RM, Coleman J, Dellicour S, Hill J, Majeres-Lugand M, Mangiaterra V, Menendez C, Mitchell K, Roman E, Sicuri E, Tagbor H, van Eijk AM, Webster J (2015). Global Call to Action to scale-up coverage of intermittent preventive treatment of malaria in pregnancy: seminar report. Malaria Journal 14:206. |
|
|
Amankwah S, Anto F (2019). Factors Associated with Uptake of Intermittent Preventive Treatment of Malaria in Pregnancy: A Cross-Sectional Study in Private Health Facilities in Tema Metropolis, Ghana. Journal of Tropical Medicine pp. 1-11 |
|
|
Amoakoh?Coleman M, Arhinful DK, Klipstein?Grobusch K, Ansah EK, Koram KA (2020). Coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) influences delivery outcomes among women with obstetric referrals at the district level in Ghana. Malaria Journal 19:222. |
|
|
Anchang-Kimbi JK, Kalaji LN, Mbacham HF, Wepnje GB, Apinjoh TO, Ngole Sumbele IU, Dionne-Odom J, Tita ATN, Achidi EA (2020). Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon. Malaria Journal 19(1):100. |
|
|
Andrews KG, Lynch M, Eckert E, Gutman J (2015). Missed opportunities to deliver intermittent preventive treatment for malaria to pregnant women 2003GÇô2013: a systematic analysis of 58 household surveys in sub- Saharan Africa. Malaria Journal 14:521. |
|
|
Arnaldo P, Rovira?Vallbona E, Langa JS, Salvador C, Guetens P, Chiheb D, Xavier B, Kestens L, Enosse SM, Rosanas?Urgell A (2018). Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique. Malaria Journal 17:109. |
|
|
Azizi SC (2020). Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016. BMC Public Health 20(1):335. |
|
|
Azizi SC, Chongwe G, Chipukuma H, Jacobs C, Zgambo J, Michelo C (2018). Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study. BMC Pregnancy Childbirth 18(1):108. |
|
|
Buh A, Kota K, Bishwajit G, Yaya S (2019). Prevalence and Associated Factors of Taking Intermittent Preventive Treatment in Pregnancy in Sierra Leone. Tropical medicine and infectious disease 4(1):32. |
|
|
Chaponda EB, Chandramohan D, Michelo C, Mharakurwa S, Chipeta J, Chico RM (2015). High burden of malaria infection in pregnant women in a rural district of Zambia: a cross-sectional study. Malaria Journal 14:380. |
|
|
Cohee LM, Kalilani-Phiri L, Boudova S, Joshi S, Mukadam R, Seydel KB, Mawindo P, Thesing P, Kamiza S, Makwakwa K, Muehlenbachs A, Taylor TE, Laufer MK (2014). Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment. Malaria Journal 13:274. |
|
|
Diengou NH, Cumber SN, Nkfusai CN, Mbinyui MS, Viyoff VZ, Bede F, Akwah L, Tsoka-Gwegweni JM, Anchang-Kimbi J (2020). Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon. Pan African Medical Journal 35:42. |
|
|
Fokam EB, Ngimuh L, Anchang-Kimbi JK, Wanji S (2016). Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon. Malaria Journal 15:172. |
|
|
Hill J, Hoyt J, van Eijk AM, D'Mello-Guyett L, ter Kuile FO, Steketee R, Smith H, Jayne Webster J (2013). Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Medicine 10(7):e1001488 |
|
|
Ibrahim H; Maya ET; Issah K; Apanga PA; Bachan EG; Noora CL (2017). Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in Sunyani Municipality, Ghana. The Pan African Medical Journal 28:122. |
|
|
Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, ter Kuile FO (2013). Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA 309(6):594-604. |
|
|
Mikomangwa WP, Minzi O, Mutagonda R, Baraka V, Mlugu EM, Aklillu E, Kamuhabwa AAR (2020). Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania. Malaria Journal 19(1):160. |
|
|
Mlugu EM, Minzi O, Asghar M, Färnert A, Kamuhabwa AAR, Aklillu E (2020). Effectiveness of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women. Pathogens 9(3):207. |
|
|
Mpogoro FJ, Matovelo D, Dosani A, Ngallaba S, Mugono M, Mazigo HD (2014). Uptake of intermittent preventive treatment with sulphadoxinepyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania. Malaria Journal 13:455. |
|
|
Mubyazi GM, Byskov J, Magnussen P, Bygbjerg IC, Ijumba JN, Marero M, Mboera LEG, Molteni M, Bloch P (2014). Health facility-based data on women receiving sulphadoxine-pyrimethamine during pregnancy in Tanzania: lessons to learn from a cross-sectional survey in Mkuranga and Mufindi districts and other national survey reports. Reproductive Health 11:6. |
|
|
Mutagonda RF, Kamuhabwa AAR, Minzi OMS, Massawe SN, Maganda BA, Aklillu E (2016). Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women. Malaria journal 15:278. |
|
|
Nkoka O, Chuang TW, Chen YH (2018). Association between timing and number of antenatal care visits on uptake of intermittent preventive treatment for malaria during pregnancy among Malawian women. Malaria Journal 17(1):211. |
|
|
Olaleye AO, Walker O (2020). Impact of Health Systems on the Implementation of Intermittent Preventive Treatment for Malaria in Pregnancy in Sub-Saharan Africa: A Narrative Synthesis. Tropical Medicine and Infectious Disease 5(3):134. |
|
|
Protas J, Tarimo D, Moshiro C (2016). Determinants of timely uptake of ITN and SP (IPT) and pregnancy time protected against malaria in Bukoba, Tanzania. BMC Research Notes 9:318. |
|
|
Orish VN, Onyeabor OS, Boampong JN, Afoakwah R, Nwaefuna E, Acquah S, Sanyaolu AO, Iriemenam NC (2015). Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana. African Health Sciences 5(4):1087-96. |
|
|
Quakyi I, Tornyigah B, Houze E, Kusi KA, Coleman N, Escriou G, Laar A, Cot M, Fobil J, Asare GQ, Deloron P, Anang AK, Cottrell G, Ofori MF, Ndam NT (2019). High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana. , Scientific Reports 9:19034. |
|
|
Rantala AM, Taylor SM, Trottman PA, Luntamo M, Mbewe B, Maleta K, Kulmala T, Ashorn P, Meshnick SR (2010). Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women. Malaria Journal 9:269. |
|
|
Roman E, Andrejko K, Wol f K, Marianne H, Youll S, Florey L, Ferenchick E, Gutman JR (2019). Determinants of uptake of intermittent preventive treatment during pregnancy: a review. Malaria Journal 18:372. |
|
|
Thiam S, Kimotho V, Gatonga P (2013). Why are IPTp coverage targets so elusive in sub-Saharan Africa? A systematic review of health system barriers. Malaria Journal 12:353.. |
|
|
Toure OA, C Konan CB, Kouame VN, Gbessi EA, Soumahoro A, Bassinka I, Jambou R (2020). Risk factors for placental malaria and associated low birth weight in a rural high malaria transmission setting of Cote d'Ivoire. Tropical Parasitology 10(2):102-108. |
|
|
Toure OA, Kone PL, Coulibaly MA, Ako BA, Gbessi EA, Coulibaly B, N' Guessan LT, Koffi D, Beourou S, Soumahoro A, Bassinka I, Nogbou M, Swa T, Gba B, Esmel B, Bokossa EM (2014). Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation. Parasites and Vectors 7:495. |
|
|
Vanga-Bosson HA, Coffie PA, Kanhon S, Sloan C, Kouakou F, Eholie SP, Kone M, Dabis F, Menan H, Ekouevi DK (2011). Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire. Malaria Journal 10:105. |
|
|
van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DEC, Roper C, Okell LC, Desai M, Gutman J, Khairallah C, Rogerson SJ, Sibley CH, Meshnick SR, Taylor SM, ter Kuile FO (2019). Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infectious Diseases 19:546-556. |
|
|
World Health Organization (WHO) (2004). A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville, World Health Organization, Regional Office for Africa. |
|
|
World Health Organization (WHO) (2012). Evidence Review Group: Intermittent Preventive Treatment of malaria in pregnancy (IPTp) with Sulfadoxine-Pyrimethamine (SP). WHO Headquarters, Geneva. Meeting report |
|
|
World Health Organization (WHO) (2018). Intermittent preventive treatment in pregnancy (IPTp). Geneva: World Health Organization. |
|
|
World Health Organization (WHO) (2016). World malaria report 2016. Geneva: World Health Organization. |
|
|
Webster J, Ansariadi, Burdam FH, Landuwulang CUR, Bruce J, Poespoprodjo JR, Syafruddin D, Ahmed R, Hill J (2018). Evaluation of the implementation of single screening and treatment for the control of malaria in pregnancy in Eastern Indonesia: a systems effectiveness analysis. Malaria Journal 17(1):310. |
|
|
Yaya S, Uthman OA, Amouzou A, Bishwajit G (2018). Use of intermittent preventive treatment among pregnant women in sub-Saharan Africa: evidence from malaria indicators surveys. Tropical Medicine and Infectious Disease 3:18. |
|
|
Yoah AT, Fru-Cho J, Kah E, Njukang E, Wirsiy FS, Duamor CT, Nkuo-Akenji T (2018). Impact of Adherence to a Full Course of Intermittent Preventive Treatment of Malaria in Pregnancy on Pregnancy Outcome in Muyuka Health District: A Cross-Sectional Study. International Archives of Public Health and Community Medicine 2:008. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
